CD9 and plasma cell myeloma: Interestingly, the transfection of myeloma cell lines with CD9 was reported to increase their susceptibility to lysis by NK and T-cells (Shallal and Kornbluth, 2000), offering a potential explanation for how CD9 downregulation could benefit tumor cells.